bioAffinity Technologies, Inc. (BIAF) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $47.45K; Additional Paid in CapitalUSD $79.27M; Retained Earnings (Accumulated Deficit)USD $-75.55M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $31.46K; Additional Paid in CapitalUSD $75.81M; Retained Earnings (Accumulated Deficit)USD $-72.18M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $31.46K; Additional Paid in CapitalUSD $75.80M; Retained Earnings (Accumulated Deficit)USD $-68.55M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $24.26K; Additional Paid in CapitalUSD $74.29M; Retained Earnings (Accumulated Deficit)USD $-65.42M.
bioAffinity Technologies, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Stock Split USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00 | $47.45K | $79.27M | $-75.55M | $3.77M | 3 month · $511.45K 6 month · $511.45K | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.00 | $31.46K | $75.81M | $-72.18M | $3.65M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.00 | $31.46K | $75.80M | $-68.55M | $7.28M | 12 month · $1.77M | 12 month · $6.75M | (m) | (m) | (m) |
| 2025-09-30 | $1.00 | $24.26K | $74.29M | $-65.42M | $8.90M | 3 month · $1.06M 9 month · $1.42M | 3 month · $4.42M 9 month · $4.42M | (m) | (m) | (m) |
| 2025-06-30 | (m) | $197.24K | $58.03M | $-60.37M | $-2.14M | 3 month · $8.77K 6 month · $356.07K | (m) | (m) | (m) | (m) |
| 2025-05-22 | (m) | $5.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $124.78K | $57.62M | $-56.30M | $1.44M | 3 month · $347.30K | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $3.55K | $56.24M | $-53.64M | $2.60M | 12 month · $1.26M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $90.06K | $53.71M | $-50.68M | $3.12M | 3 month · $290.17K 9 month · $785.17K | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $79.41K | $52.03M | $-48.68M | $3.43M | 6 month · $495.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $78.52K | $51.74M | $-46.57M | $5.26M | 3 month · $495.00K | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $65.76K | $49.39M | $-44.60M | $4.86M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $64.53K | $49.16M | $-42.23M | $6.99M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $59.89K | $47.98M | $-39.94M | $8.10M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $59.24K | $47.81M | $-38.20M | $9.67M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $58.67K | $47.65M | $-36.67M | $11.04M | (m) | 12 month · $462.34K | 12 month · $-185.00 | 12 month · $-185.00 | 12 month · $352.25K |
| 2022-09-30 | (m) | $58.59K | $47.53M | $-34.99M | $12.60M | (m) | 3 month · $165.72K | 3 month · $134.28K 9 month · $348.22K | 9 month · $-185.00 | 3 month · $165.72K 9 month · $383.70K |
| 2022-06-30 | (m) | (m) | (m) | (m) | $-16.79M | (m) | 6 month · $217.97K | 6 month · $213.94K | 6 month · $-185.00 | 3 month · $-185.00 6 month · $217.97K |
| 2022-03-31 | (m) | (m) | (m) | (m) | $-16.72M | (m) | (m) | 3 month · $213.94K | (m) | 3 month · $217.97K |
| 2021-12-31 | (m) | $18.74K | $12.70M | $-28.51M | $-15.79M | (m) | 12 month · $4.08M | 12 month · $739.60K | (m) | 12 month · $745.60K |
| 2021-09-30 | (m) | (m) | (m) | (m) | $-15.69M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | $-14.16M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | $-15.07M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |